Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Carlo, Lanza"'
Autor:
Dolaji Henin, Gaia Pellegrini, Daniela Carmagnola, Giuseppe Carlo Lanza Attisano, Gianluca Lopez, Stefano Ferrero, Antonella Amendola, Danilo De Angelis, Elisabetta Tanzi, Claudia Dellavia
Publikováno v:
Cells, Vol 11, Iss 7, p 1248 (2022)
COVID-19, a recently emerged disease caused by SARS-CoV-2 infection, can present with different degrees of severity and a large variety of signs and symptoms. The oral manifestations of COVID-19 often involve the tongue, with loss of taste being one
Externí odkaz:
https://doaj.org/article/e2a6c714a72c45d89f7a22ce6f2674d6
Publikováno v:
International Journal of Legal Medicine. 137:459-470
The capability of discriminating between a vital and a post-mortem injury has always been a central theme in forensic pathology, particularly when the corpse is an advanced state of decomposition. Post-mortem decay of the body can mask or disrupt the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e798cf836e69fc0b1672a0b4d3ae23b1
https://doi.org/10.1007/s00414-022-02932-9
https://doi.org/10.1007/s00414-022-02932-9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elena Garralda, Alonso Guzman, Juanita Lopez, Vicky Sanchez-Perez, Heinz Läubli, Emiliano Calvo, Christoph Huber, Nicole Egli, Aswathy Nair, Julie Mouton, Kirsten Richter, Carlo Lanza, Sangeeta Jethwa, Silvio Costanzo, Christoph Bucher
Publikováno v:
Cancer Research. 82:CT140-CT140
Developing a safe and effective non-alpha IL-2R agonist to enhance the numbers and activation status of immune effector cells for the treatment of cancer has remained an elusive goal since the initial approval of Interleukin-2 (IL-2). ANV419 comprise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15e499f791c3b0efb192f0d72ea4ad17
https://doi.org/10.1158/1538-7445.am2022-ct140
https://doi.org/10.1158/1538-7445.am2022-ct140
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy
Autor:
Begoña de las Heras, Manuela Leone, Carlo Lanza, Marco Romano, Giuseppe Curigliano, Evandro de Azambuja, Javier Cortes, Chris Twelves, Sibylle Loibl, Kamal S Saini, Mrinal M. Patnaik, Javier de Castro, Monika Lamba Saini
Publikováno v:
British Journal of Cancer
Scientia
Scientia
Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62decff0c66baa3058e98b3021e97be4
https://pubmed.ncbi.nlm.nih.gov/32572174
https://pubmed.ncbi.nlm.nih.gov/32572174
Autor:
Carlo Lanza
Introduzione al volume con particolare riguardo alla considerazione del diritto romano in Cassazione nella seconda metà dell'Ottocento.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3977::8fb1737968f37a6b6c5f0cf2ee5c8138
http://hdl.handle.net/11591/395591
http://hdl.handle.net/11591/395591
